Tag: DGCI
Aurobindo Pharma, MSN Labs seek DCGI nod for Phase-III trials of...
Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....
DGCI nod for Apheresis machine to extract blood plasma
Panaji: Goa has made a new breakthrough in its plasma therapy for critically ill COVID-19 patients after Drugs Controller General of India (DGCI) gave its approval...
Latest posts
Drug alert: 42 out of 1227 samples declared as NSQ in...
Download the list of NSQ samples for September 2021: The Central Drugs Standard Control Organisation (CDSCO) has declared 42 drug samples out...
Authors
